Nanobiotix SA at Jefferies London Healthcare Conference Transcript
Good afternoon. My name is Peter Welford; I'm one of the European pharma and biotech analysts at Jefferies in London. It's my great pleasure to introduce the next company in this track, which is Nanobiotix. And here to walk -- brief presentation and then we'll do some Q&A. And from Nanobiotix today, we have the CEO, Laurent Levy, who's going to talk you through his few slides; and then we also have the CFO with me at the front here, Bart Van Rhijn. And I think it was right, you think?
And so we will start off, as I said, over to you, Laurent, with that. And then we'll kick off with some Q&A. (Conference Instructions) We'd love to get some questions.
And with that, over to you. Thank you very much.
Thank you, Peter, and thank you, everyone, for being here. Happy to have this new conference in presence. That's always nice. Today, we're going to talk about Nanobiotix and make -- focus on our primary plan, which is to build a franchise in head and neck with our lead
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
